Evozyne
Alan Sulpizio, PhD, currently serves as a Research Scientist and Associate Technical Manager at Evozyne since April 2022. Prior to this role, Alan spent nearly seven years at Cornell University as a Research Biochemist, where significant contributions included elucidating a two-step regulatory mechanism of a Legionella-derived modification crucial for bacterial infection and identifying a novel pseudokinase involved in posttranslational modification. Alan's earlier experience includes research at Michigan State University's Brandizzi Lab and positions as an Analytical Chemist at Pfizer, alongside instructional roles in physics. Alan holds a PhD in Biochemistry, Molecular and Cell Biology from Cornell University and a BS in Biochemistry and Biotechnology from Michigan State University.
Evozyne
1 followers
Evozyne combines evolution and deep learning technology to create highly functional novel proteins — Natural Machines™ — to solve longstanding challenges in therapeutics and sustainability. By amplifying a protein’s function based on the rules of nature, we address complex, high-impact problems. From developing life-changing patient treatments to making carbon capture a reality, Evozyne is committed to making a healthier, more sustainable world.